Kanis, J. A.
Johansson, H.
Harvey, N. C.
Gudnason, V.
Sigurdsson, G.
Siggeirsdottir, K.
Lorentzon, M.
Liu, E.
Vandenput, L.
McCloskey, E. V.
Article History
Received: 8 May 2020
Accepted: 1 June 2020
First Online: 1 July 2020
Compliance with ethical standards
: The study was approved by the National Bioethics Committee and the Data Protection Authority in Iceland. All participants gave informed written consent.
: V Gudnason, G Sigurdsson, K Siggeirsdottir, E Liu, L Vandenput and H Johansson have no competing interests to declare.N. Harvey has received consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health and Internis Pharma.EV McCloskey has received consultancy/lecture fees/grant funding/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, SanofiAventis, Servier, Synexus, UCB, Viiv, Warner Chilcott, I3 Innovus and Unilever.JA Kanis reports grants from Amgen, Eli Lilly and Radius Health and consulting fees from Theramex. JAK is the architect of FRAX® but has no financial interest.M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma, and UCB Pharma and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health, all outside the presented work.